Anti-CIP1
Anti-p21
Anti-SD11
Anti-WAF

Host: Mouse

Isotype: IgG1

Immunogen: full-length, recombinant human p21WAF1

Epitope: within amino acids 58-77 of human p21WAF1

Form: Liquid

Formulation: In 0.05 M sodium phosphate buffer, 0.2% gelatin.

Preservative: ≤0.1% sodium azide

Positive Control: Any cell line expressing wild-type p53 (e.g. Hs27 or U2Os cells treated with DNA-damaging agents)

Comments: Recognizes the ~21 kDa p21WAF1 protein in skin or colon tissue and in cells expressing wild-type p53 (e.g. Hs27 or U205 cells treated with DNA damaging agents).

Ref.: Agarwal, M.L., et al. 1995 Proc. Natl. Acad. Sci. USA 92, 8493. Chen, Y.Q., et al. 1995. Int. J. Oncology 7, 889. Deng, C., et al. 1995 Cell 82, 675. El-Deiry, W.S., et al. 1995 Cancer Res. 55, 2910. Waldman, T., et al. 1995 Cancer Res. 55, 5187. El-Deiry, W.S., et al. 1994 Cancer Res. 54, 1169. Elbendary, A., et al. 1994 Cell Growth Diff. 5, 1301. Li, R., et al. 1994 Nature 371, 534. Michieli, P., et al. 1994 Cancer Res. 54, 3391. Noda, A., et al.1994. Exp. Cell Res. 211, 90. El-Deiry, W.S., et al. 1993. Cell 75 817. Gu, Y., et al. 1993. Nature 366, 707. Harper, J.W., et al. 1993 Cell 75, 805. Xiong, Y., et al. 1993. Genes Devel. 7, 1572. Xiong, Y., et al. 1993. Nature 366, 701. Xiong, Y., et al. 1992. Cell 71, 505.